Clinical Trials on Prostate Specific Antigens
Total 8319 results
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneNational Cancer Institute, FranceCompleted
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
Radboud University Medical CenterCompleted
-
Chang Gung Memorial HospitalUnknownProstate AdenocarcinomaTaiwan
-
Fundacao ChampalimaudCompleted
-
Rennes University HospitalCenter Eugene MarquisCompletedProstate Cancer | Prostate AdenocarcinomaFrance
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
University College London HospitalsCompleted
-
Tufts UniversityCompletedProstate NeoplasmUnited States
-
Albert DeNittisUnknown
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
University of CincinnatiUnknownCastration-resistant Prostate Cancer | Cancer of the ProstateUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial Hospital; Chang Gung Memorial Hospital; Taipei Veterans... and other collaboratorsRecruiting
-
Dana MathewsCompletedProstate Cancer | Prostate Cancer MetastaticUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate Cancer PatientsUnited States
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedOligometastatic Prostate CancerSpain
-
Sun Pharmaceutical Industries LimitedCompleted
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
Portland VA Medical CenterNational Cancer Institute (NCI); OHSU Knight Cancer Institute; Oregon State UniversityCompletedProstate Cancer PreventionUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Institut Claudius RegaudCompleted
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Burzynski Research InstituteTerminatedMetastatic Prostate CancerUnited States
-
Astellas Pharma Europe Ltd.Terminated
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
SanofiCompletedProstate Cancer MetastaticIndia
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
DexTech Medical ABCompletedProstate Cancer MetastaticSweden
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
University of Turin, ItalyUnknownAdvanced Prostate CancerItaly
-
AstraZenecaCompletedAdvanced Prostate CancerCroatia
-
Turku University HospitalRecruitingProstate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate CancerFinland
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
IpsenActive, not recruitingMetastatic Prostate Cancer | Advanced Prostate Cancer | Locally Advanced Prostate CancerChina